- Home
- Clinical Trials
Cardiovascular Disease Study Sydney DH 2022
Cardiovascular Disease Study
Darlinghurst Sydney
Living with heart disease and worried you’ll experience another heart event?
Join a clinical research study evaluating an investigational medication aimed at reducing the risk of heart attacks, strokes and other serious cardiovascular events in individuals with established heart disease.
This study could lead to a potential new treatment that not only reduces the risk of serious cardiovascular events but also helps manage the effects of obesity on heart health and improve overall quality of life for those living with both conditions.
Description
What to expect
Study details
Ages
45 years or older
Duration
Up to 5 years and will include both in-clinic visits and telephone follow-ups
Compensation
Participants will be reimbursed for reasonable expenses associated with study visits
Eligibility Criteria
You may qualify for this study if you:
- Are 45 years or older
- Have a body mass index (BMI) of 27 or higher
- Have a history of cardiovascular disease – such as a prior heart attack, stroke or narrowed arteries
This study may not be right for you if you:
- Have had a recent heart attack, stroke, or heart surgery (within the past 60 days)
- Have type 1 diabetes, advanced kidney disease, or certain other serious medical conditions
Other eligibility criteria will apply.
This study will be conducted at Momentum Darlinghurst
Locations
Description
Cardiovascular disease is a chronic condition that affects the heart, blood vessels and overall health. The disease is serious and widespread, making everyday life more difficult for many people – causing fatigue, shortness of breath, chest pain and increased risk of heart attacks or strokes.
Excess weight places extra strain on the heart and contributes to inflammation and other risk factors. Over time, this can lead to lasting damage and reduced quality of life. Cardiovascular disease remains the leading cause of death globally, and obesity rates continue to rise at an alarming rate.
Current treatments often focus on managing symptoms, through medications and lifestyle changes - but many people still face a high risk of future heart problems.
This study is exploring a new treatment approach that aims to improve heart health, reduce cardiovascular events, and support sustained weight loss - potentially leading to better long-term outcomes and quality of life.
What to expect
The treatment works by targeting specific hormones in the body that regulates appetite, metabolism and inflammation - all of which are closely linked to heart health and obesity.
Participants will receive a monthly injection, with the dose gradually increased over time to support comfort and tolerability. During the time of the study, you will visit the clinic regularly and our medical team will monitor your health.
The goal is to not only support meaningful, sustained weight loss, but also improve heart health and overall quality of life.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.